期刊文献+

近30年来慢性心力衰竭住院患者合并肾功能不全的回顾性分析 被引量:6

Retrospective Analysis of Hospitalized Chronic Heart Failure Patients with Renal Dysfunction for Recent 30 Years
下载PDF
导出
摘要 目的:分析近30年来慢性心力衰竭(心衰)住院患者合并肾功能不全的发生率、临床特点及治疗情况。方法:采用回顾性方法,分析慢性心力衰竭患者合并肾功能不全的发生率,以肾小球滤过率将心衰患者分为A(肾功能正常)、B(肾功能轻度受损)、C(肾功能不全)3组,以入院年代将心衰合并肾功能不全患者(C组)分为Ⅰ(1980年1月—1989年12月)、Ⅱ(1990年1月—1999年12月)、Ⅲ(2000年1月—2007年8月)3组,分析临床特点和治疗情况。结果:入选2459例,其中合并肾功能不全者714例(29.0%)。与A组、B组患者相比,C组患者年龄较大,合并高血压病、糖尿病、贫血、低钠血症的比例较高,左心室射血分数较低,且住院时间较长、住院病死率较高,利尿剂、洋地黄应用比例较高,而血管紧张素转化酶抑制剂(ACEI)、β-受体阻滞剂使用比例较低(均P<0.01)。结论:慢性心力衰竭患者合并肾功能不全的发生率较高,年龄较大、心功能差、住院时间较长、住院病死率较高,治疗仍以硝酸酯、利尿剂、洋地黄为主,而ACEI、β-受体阻滞剂的应用比例较低,与指南差距较大。 Objective: To analyze the incidence, clinical feature and drug treatment of hospitalized chronic heart failure (CHF) patients with renal dysfunction for recent 30 years. Methods: Applying retrospective method to describe the incidence of hospitalized CHF patients with renal dysfunction. According to glomerular filtration rate and eras, all the CHF patients and CHF with renal dysfunction patients were divide into three groups which included group A with normal renal function, group B with mild renal function damage, and group C with renal dysfunction. According to the hospitalized time, all patients were divided into group Ⅰ (1980.01--1989.12), group Ⅱ (1990.01--1999. 12), and group Ⅲ (2000.01--2007.08), and the clinical feature and drug treatment were analyzed. Results: In all 2 459 complete data cases, 714 (29.0%) cases had renal dysfunction. Compared with group A and B, the patients in group C were elder, the proportion of hypertension, diabetes, aneamia, hyponatremia and cardic function NYHA Ⅳ was higher, left ventricular ejection fraction was lower, hospital stay was longer, and in-hospital case-fatality rate was higher. The usage of diuretics and digitalis was higher, but the usage of an- giotensin converting enzyme inhibitor (ACEI) and 13-blocker was lower (P 〈 0.01). Conclusion: The incidence of renal dysfunction was higher in CHF patients. The age was elder, cardiac function was worse, hospital stay was longer, and in-hospital case-fatality rate was higher in the patients with renal dysfunction. The usage of diuretics and digitalis was higher, while the usage of ACEI and β- blocker was lower than the guidlines.
出处 《天津医药》 CAS 北大核心 2009年第4期261-265,共5页 Tianjin Medical Journal
基金 吴阶平医学基金会资助项目(项目编号:2003-58-A)
关键词 心力衰竭 充血性 肾功能衰竭 药物疗法 回顾性研究 heart failure, congestive kidney failure drug therapy retrospective studies
  • 相关文献

参考文献11

  • 1Ma YC, Zuo L, Chen JH, et al. Modified glomerular fihration rate estimating equation for Chinese patients with chronic kidney disease [J]. J Am Soc Nephrol, 2006, 17(10): 2937-2944. 被引量:1
  • 2程康安,吴宁.中国部分地区1980、1990、2000年慢性心力衰竭住院病例回顾性调查[J].中华心血管病杂志,2002,30(8):450-454. 被引量:361
  • 3Khan NA, Ma I, Thompson CR, et al. Kidney function and mortality among patients with left ventricular systolic dysfunction [J]. J Am Soc Nephrol, 2006, 17(1): 244 -253. 被引量:1
  • 4Smith GL, Lichtman JH, Bracken MB, et al. Renal impairment and outcomes in heart failure: systematic review and meta-analysis [J]. J Am Coll Cardiol, 2006, 47(10): 1987-1996. 被引量:1
  • 5Heywood JT, Fonarow GC, Costanzo MR, et al. High prevalence of renal dysfunction and its impact on outcome in 118,465 patients hospitalized with acute decompensated heart failure: a report from the ADHERE database[J], J Card Fail, 2007, 13(6): 422-430. 被引量:1
  • 6Silverberg DS,Wexler D,Blum M, et al. The interaction between heart failure, renal failure and anemia-the cardio-renal aAnemia syndrome[J].Blood Purif, 2004, 22(3): 277-284. 被引量:1
  • 7Ezekowitz J, McAlister FA, Humphries KH, et al. The association among renal insufficiency, pharmacotherapy, and outcomes in 6427 patients with heart failure and coronary artery disease [J]. J Am Coil Cardiol, 2004, 44(8): 1587-1592. 被引量:1
  • 8McAlister FA, Ezekowitz J, Tonelli M, et al. Renal insufficiency and heart failure:prognostic and therapeutic implications from a prospective cohort study[J]. Circulation, 2004, 109 (8): 1004-1009. 被引量:1
  • 9Hou FF, Zhang X, Zhang GH, et al. Efficacy and safety of benazepril for advanced chronic renal insufficiency[J]. N Engl J Med, 2006, 354 (2): 131-140. 被引量:1
  • 10Hunt SA, Baker DW, Chin MH, et al. ACC/AHA guidelines for the evaluation andmanagement of chronic heart failure in the adult [J]. J Am Coll Cardiol, 2001, 38(7):2101-2113. 被引量:1

二级参考文献7

  • 1Kalon KL,Joan LP, William BK. The epidemiology of heart failure: the Framingham study. J Am Coll Cardiol, 1993,22 (Suppl A):6A-13A. 被引量:1
  • 2Hung YT, Cheug NT, Ip S. Epidemiology of heart failure in Hong Kong,1997. Hong Kong Med J, 2000,6:159-162. 被引量:1
  • 3Packer M, Coats AJS, Fowler MB, et al. For the Carvedilol Prospective Randomized Cumulative Survival Study Group. Effects of carvedilol on survival in severe chronic heart failure. N Engl J Med, 2001, 344:1651-1658. 被引量:1
  • 4Remme WJ, Swedberg K. Guidelines for the diagnosis and treatment of chronic heart failure. Task force for the diagnosis and treatment of chronic heart failure, European Society of Cardiology. Eur Heart J, 2001, 22: 1527-1561. 被引量:1
  • 5Hunt HA, Baker DW, Chin MH, et al. ACC/AHA Guidelines for the Evaluation and Management of Chronic Heart Failure in the Adult: Executive Summary A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Revise the 1995 Guidelines for the Evaluation and Management of Heart Failure). Developed in collaboration with the international society for heart and lung transplantation. Circulation, 2001, 104:2996-3007. 被引量:1
  • 6上海市心力衰竭调查协作组,范维琥,张平宽,李勇.上海市稳定性心力衰竭患者药物治疗现状调查[J].中华心血管病杂志,2001,29(11):644-648. 被引量:37
  • 7慢性收缩性心力衰竭治疗建议[J].中华心血管病杂志,2002,30(1):7-23. 被引量:2414

共引文献360

同被引文献41

引证文献6

二级引证文献75

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部